Authors: Gulbrandsen, N Wisloff, F Brinch, L Carlson, K Dahl, IM Gimsing, P Hippe, E Hjorth, M Knudsen, LM Lamvik, J Lenhoff, S Lofvenberg, E Nesthus, I Nielsen, JL Turesson, L Westin, J

Citation: N. Gulbrandsen et al., Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support, MED ONCOL, 18(1), 2001, pp. 65-77

Authors: Salomo, M Gimsing, P

Citation: M. Salomo et P. Gimsing, Bisphosphonates and in vivo models of multiple myeloma, BR J HAEM, 113(3), 2001, pp. 841-842

Authors: Lenhoff, S Hjorth, M Holmberg, E Turesson, I Westin, J Nielsen, JL Wisloff, F Brinch, L Carlson, K Carlson, M Dahl, IM Gimsing, P Hippe, E Johnsen, H Lamvik, J Lofvenberg, E Nesthus, I Rodjer, S

Citation: S. Lenhoff et al., Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study, BLOOD, 95(1), 2000, pp. 7-11

Authors: Petersen, SL Wagner, A Gimsing, P

Citation: Sl. Petersen et al., Cerebral and meningeal multiple myeloma after autologous stem cell transplantation. A case report and review of the literature, AM J HEMAT, 62(4), 1999, pp. 228-233